SCYNEXIS approved a certificate of amendment authorizing an 8-for-1 reverse stock split of its common stock, reducing authorized shares to 18.75 million. The restructuring affects outstanding share count and per-share pricing metrics.
SCYNEXIS approved a certificate of amendment authorizing an 8-for-1 reverse stock split of its common stock, reducing authorized shares to 18.75 million. The restructuring affects outstanding share count and per-share pricing metrics.